Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Market Place
ABOUT THIS PAGE
79
PharmaCompass offers a list of Ademetionine 1,4-Butanedisulfonate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ademetionine 1,4-Butanedisulfonate manufacturer or Ademetionine 1,4-Butanedisulfonate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ademetionine 1,4-Butanedisulfonate manufacturer or Ademetionine 1,4-Butanedisulfonate supplier.
PharmaCompass also assists you with knowing the Ademetionine 1,4-Butanedisulfonate API Price utilized in the formulation of products. Ademetionine 1,4-Butanedisulfonate API Price is not always fixed or binding as the Ademetionine 1,4-Butanedisulfonate Price is obtained through a variety of data sources. The Ademetionine 1,4-Butanedisulfonate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A SAMe-1,4-Butanedisulfonate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of SAMe-1,4-Butanedisulfonate, including repackagers and relabelers. The FDA regulates SAMe-1,4-Butanedisulfonate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. SAMe-1,4-Butanedisulfonate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of SAMe-1,4-Butanedisulfonate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A SAMe-1,4-Butanedisulfonate supplier is an individual or a company that provides SAMe-1,4-Butanedisulfonate active pharmaceutical ingredient (API) or SAMe-1,4-Butanedisulfonate finished formulations upon request. The SAMe-1,4-Butanedisulfonate suppliers may include SAMe-1,4-Butanedisulfonate API manufacturers, exporters, distributors and traders.
click here to find a list of SAMe-1,4-Butanedisulfonate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A SAMe-1,4-Butanedisulfonate DMF (Drug Master File) is a document detailing the whole manufacturing process of SAMe-1,4-Butanedisulfonate active pharmaceutical ingredient (API) in detail. Different forms of SAMe-1,4-Butanedisulfonate DMFs exist exist since differing nations have different regulations, such as SAMe-1,4-Butanedisulfonate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A SAMe-1,4-Butanedisulfonate DMF submitted to regulatory agencies in the US is known as a USDMF. SAMe-1,4-Butanedisulfonate USDMF includes data on SAMe-1,4-Butanedisulfonate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The SAMe-1,4-Butanedisulfonate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of SAMe-1,4-Butanedisulfonate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a SAMe-1,4-Butanedisulfonate Drug Master File in Korea (SAMe-1,4-Butanedisulfonate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of SAMe-1,4-Butanedisulfonate. The MFDS reviews the SAMe-1,4-Butanedisulfonate KDMF as part of the drug registration process and uses the information provided in the SAMe-1,4-Butanedisulfonate KDMF to evaluate the safety and efficacy of the drug.
After submitting a SAMe-1,4-Butanedisulfonate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their SAMe-1,4-Butanedisulfonate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of SAMe-1,4-Butanedisulfonate suppliers with KDMF on PharmaCompass.
SAMe-1,4-Butanedisulfonate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of SAMe-1,4-Butanedisulfonate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right SAMe-1,4-Butanedisulfonate GMP manufacturer or SAMe-1,4-Butanedisulfonate GMP API supplier for your needs.
A SAMe-1,4-Butanedisulfonate CoA (Certificate of Analysis) is a formal document that attests to SAMe-1,4-Butanedisulfonate's compliance with SAMe-1,4-Butanedisulfonate specifications and serves as a tool for batch-level quality control.
SAMe-1,4-Butanedisulfonate CoA mostly includes findings from lab analyses of a specific batch. For each SAMe-1,4-Butanedisulfonate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
SAMe-1,4-Butanedisulfonate may be tested according to a variety of international standards, such as European Pharmacopoeia (SAMe-1,4-Butanedisulfonate EP), SAMe-1,4-Butanedisulfonate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (SAMe-1,4-Butanedisulfonate USP).
